Frequency
Minority shareholders will have to reinvest their $44 billion somewhere after the buyout. What about a spinoff?
6:59AM 07/23/08
Analysts on Wall Street consider the $89-a-share offer a low-ball bid; it could spur further M&A activity in the sector, however.
10:30AM 07/21/08
The trading panel considers the potential ripples from the Fannie and Freddie trouble.
7:03PM 07/11/08
Here's what to look for when these seven big biotech companies report upcoming results for the second quarter.
10:23AM 07/11/08
It pays to follow sector rotation, but the key is to discern what areas cash is flowing to and then getting there.
11:08AM 07/08/08
Dan Fitzpatrick examines three stocks viewed on 'Mad Money' and 'Fast Money'. Today's stocks include Genentech, Ram Energy and XTO Energy.
09:00AM 07/08/08
Examining Amgen's discount; updating MiddleBrook; valuing Seattle Genetics; and comparing SuperGen to Celgene.
7:59AM 07/04/08
Maxygen climbs on news of a deal with Bayer HealthCare.
4:16PM 07/02/08
The trading panel says the company could be a target with a big six months ahead of it.
7:00PM 07/01/08
Dacogen's failed trial in myelodysplastic syndromes opens the door to greater market share for Celgene's Vidaza.
3:11PM 07/01/08
Our Experts' Take at RealMoney
Today's strong action should lead to more upside in this leading biotech stock.
3:48PM 07/23/08
The very stocks that had been most heavily shorted are rallying the hardest.
11:47AM 07/23/08
More Experts' Takes
More popular tickers are indicated by scale.
